2007, Sales and Side effects - Pharma Rep Focus

Beating the Big C

Pharmaceutical Technology

JULY 23, 2008

It has boosted anti-tumour research by 60% since 2005, at a cost of $1.6bn, in the hope of increasing the share of company sales attributed to cancer drugs from the current level of 5% “There are a lot of patients that are suffering,” said Pfizer chief executive Jeffrey Kindler. So what’s driving the growth?

Side effects

Side effects Marketing Pharmaceutical Sales

Interview: Dr Alan S Louie – US Food and Drug Administration Delays

Pharmaceutical Technology

AUGUST 17, 2008

NB: Recent figures show the pharmaceutical industry spent $168m lobbying congress in 2007, how successful were the industry’s efforts and what are the main administration issues concerning the industry at present? For example when Pfizer took all its advertising off after the Vioxx scare, the sales of their products went down.

Food and Drug Administration

Food and Drug Administration Food FDA Safety

Pharma Rep Focus

Beating the Big C

Interview: Dr Alan S Louie – US Food and Drug Administration Delays

Webinars

Stay Connected